What is the recommended management for full‑thickness chondral fissuring of the knee?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Full-Thickness Chondral Fissuring of the Knee

For full-thickness chondral fissuring of the knee, microfracture is the recommended first-line surgical treatment for focal, contained lesions smaller than 4 cm² in patients with minimal osteoarthritis (Tönnis grade ≤1). 1

Classification and Diagnostic Framework

Full-thickness chondral fissuring corresponds to Outerbridge Grade 4 lesions, characterized by complete loss of cartilage with exposed subchondral bone. 2 This classification system guides treatment decisions and helps predict outcomes. 1

The natural history of untreated full-thickness cartilage defects typically results in progressive disability and further cartilage loss. 3 Subchondral bone changes occur dynamically after cartilage injury, with bone resorption peaking around 14 days post-injury, followed by sclerotic changes that correlate with increased pain levels. 4

Treatment Algorithm Based on Lesion Characteristics

Lesions <4 cm² with Minimal Osteoarthritis

Microfracture is the indicated procedure, involving the following technical steps: 1

  • Debride all friable cartilage using a shaver to remove unstable tissue 2
  • Create a perpendicular edge of healthy, well-attached cartilage around the defect using ringed curettes 2
  • Penetrate subchondral bone with an awl to create 3-4 mm deep holes spaced 3-4 mm apart 2, 1
  • Preserve subchondral bone bridges between holes to maintain structural integrity 2

The mechanism relies on bringing pluripotent marrow cells and growth factors from underlying bone marrow into the defect, which form fibrocartilage to fill the lesion. 2 Studies demonstrate mean 93% ± 17% fill at second-look arthroscopy with macroscopically good-quality cartilage. 1

Lesions 2-6 cm²

  • Microfracture remains first-line for acetabular lesions 1
  • Mosaicplasty or single-plug osteochondral allograft should be considered for femoral head lesions 1

Lesions >6 cm²

Conversion to total joint arthroplasty should be considered in appropriate surgical candidates, as the defect size exceeds the reliable treatment threshold for cartilage repair techniques. 1

Critical Contraindications

Microfracture must NOT be performed for partial-thickness chondral delamination with an intact basal layer, as the technique requires exposed subchondral bone and is reserved exclusively for contained, full-thickness defects. 1 Attempting microfracture on partial-thickness lesions violates the fundamental principle that subchondral bone must be accessible for marrow cell recruitment.

Non-Surgical Adjuncts

Pain Management

  • Acetaminophen (paracetamol) is the preferred first-line oral analgesic, though efficacy is uncertain and likely small 1
  • NSAIDs can be used when acetaminophen is insufficient, but long-term use carries gastrointestinal and cardiovascular risks 1
  • Intra-articular anesthetic and steroid injections serve both diagnostic and therapeutic purposes 5

Bracing and Orthoses

  • Patellofemoral braces are conditionally recommended for patients with significant impact on ambulation, joint stability, or pain 1
  • Kinesiotaping is conditionally recommended for knee joint involvement 1
  • Optimal bracing requires clinician familiarity with various brace types and expertise in fitting 1

Interventions to Avoid

Stem cell injections for cartilage regeneration are NOT recommended due to concerns regarding heterogeneity and lack of standardization, with low-quality supporting evidence. 1

Common Pitfalls and Monitoring

The primary pitfall is attempting microfracture on inappropriate lesions—either those with intact basal cartilage layers or those in patients with advanced osteoarthritis (Tönnis grade >1). 1 The subchondral bone plate must be exposed and intact for the procedure to succeed. 2

Long-term monitoring is essential as chondromalacia may progress to osteoarthritis if not properly managed. 1 Patients with more extensive cartilage damage have less favorable outcomes and may require additional interventions. 5

At second-look arthroscopy, the wave sign (indicating chondral delamination) resolves in approximately 85% of successfully treated cases. 6 Persistent delamination at revision is associated with residual impingement, age ≥58 years, or delayed revision >6 months. 6

The repair tissue formed after microfracture is fibrocartilage rather than native hyaline cartilage, which is less durable and smooth than the original tissue. 7 However, this fibrocartilage can achieve biomechanical properties similar to normal articular cartilage by 12 weeks post-procedure. 8

References

Guideline

Chondromalacia Patella Classification and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Chondral injuries.

Current opinion in rheumatology, 2002

Guideline

Management of Hip Pain with Complex Superior Labral Tear and Mild Chondropathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Articular cartilage. Anatomy, injury, and repair.

Clinics in podiatric medicine and surgery, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.